Chemical Compound Review:
Baynas 3-[(3R)-3-[(4- fluorophenyl)sulfonylamino]...
Synonyms:
Ramatroban, PubChem9956, Bay-u-3405, SureCN29030, Baynas (TN), ...
- Thromboxane antagonism in experimental canine carotid artery thrombosis. Rote, W.E., Mu, D.X., Lucchesi, B.R. Stroke (1993)
- Effect of Bay U 3405, a new thromboxane antagonist, on collagen-induced thromboembolism in rabbits. Seuter, F., Perzborn, E., Fiedler, V.B. Stroke (1990)
- Effects of the novel thromboxane antagonist Bay U 3405 on experimental coronary artery disease. Fiedler, V.B., Seuter, F., Perzborn, E. Stroke (1990)
- Characterization of Bay U 3405, a novel thromboxane A2/endoperoxide receptor antagonist. Perzborn, E., Fiedler, V.B., Seuter, F., Stasch, J.P., Weber, H., Sander, E., Böshagen, H., Rosentreter, U. Stroke (1990)
- On the mechanism of interaction of potent surmountable and insurmountable antagonists with the prostaglandin D2 receptor CRTH2. Mathiesen, J.M., Christopoulos, A., Ulven, T., Royer, J.F., Campillo, M., Heinemann, A., Pardo, L., Kostenis, E. Mol. Pharmacol. (2006)
- Successful treatment of eosinophilic otitis media using ramatroban: Report of two cases. Wada, T., Uemaetomari, I., Murashita, H., Tobita, T., Tsuji, S., Tabuchi, K., Okubo, H., Hara, A. Auris, nasus, larynx. (2006)
- Pharmacokinetic analysis of ramatroban using a recirculatory model with enterohepatic circulation by measuring portal and systemic blood concentration difference in Sprague-Dawley and Eisai hyperbilirubinemic rats. Moriwaki, T., Yasui, H., Yamamoto, A. Pharm. Res. (2004)
- Identification of indole derivatives exclusively interfering with a G protein-independent signaling pathway of the prostaglandin D2 receptor CRTH2. Mathiesen, J.M., Ulven, T., Martini, L., Gerlach, L.O., Heinemann, A., Kostenis, E. Mol. Pharmacol. (2005)
- Characterization and localization of thromboxane A2 receptor in human and guinea-pig nasal mucosa using radiolabelled (+)-S-145. Arimura, A., Miwa, M., Hasegawa, H., Kishino, J., Notoya, M., Yasui, K., Komori, M., Iwata, S. Br. J. Pharmacol. (1998)
- Effects of thromboxane A2 receptor antagonist (Bay u 3405) on nasal symptoms after antigen challenge in sensitized guinea pigs. Narita, S., Asakura, K., Kataura, A. Int. Arch. Allergy Immunol. (1996)
- Effects of a thromboxane-receptor antagonist, BAY u 3405, on prostaglandin D2- and exercise-induced bronchoconstriction. Magnussen, H., Boerger, S., Templin, K., Baunack, A.R. J. Allergy Clin. Immunol. (1992)
- Inhibition of platelet-vessel wall interactions by thromboxane receptor antagonism in a human in vitro system: potentiation of antiplatelet effects of aspirin. Escolar, G., Albors, M., Garrido, M., Bioque, G., Díaz Ricart, M., Carretero, M., Ordinas, A. Eur. J. Clin. Invest. (1998)
- Effect of thromboxane A2-receptor antagonist on bradykinin-induced bronchoconstriction in asthma. Rajakulasingam, K., Johnston, S.L., Ducey, J., Ritter, W., Howarth, P.H., Holgate, S.T. J. Appl. Physiol. (1996)
- Thromboxane A2/prostaglandin H2 receptor activation mediates angiotensin II-induced postischemic neovascularization. Michel, F., Silvestre, J.S., Waeckel, L., Corda, S., Verbeuren, T., Vilaine, J.P., Clergue, M., Duriez, M., Levy, B.I. Arterioscler. Thromb. Vasc. Biol. (2006)
- Ramatroban, a thromboxane A2 receptor antagonist, prevents macrophage accumulation and neointimal formation after balloon arterial injury in cholesterol-fed rabbits. Ishizuka, T., Matsumura, K., Matsui, T., Takase, B., Kurita, A. J. Cardiovasc. Pharmacol. (2003)
- The effect of BAY u 3405, a thromboxane receptor antagonist, on prostaglandin D2-induced nasal blockage. Johnston, S.L., Smith, S., Harrison, J., Ritter, W., Howarth, P.H. J. Allergy Clin. Immunol. (1993)
- Improved coronary thrombolysis by tissue-type plasminogen activator in the presence of BAY U 3405. Rounding, H.P., Fiedler, V.B. Eur. J. Pharmacol. (1991)
- Involvement of thromboxane A2 in bronchial hyperresponsiveness of asthma. Kanazawa Asthma Research Group. Fujimura, M., Nakatsumi, Y., Nishi, K., Kasahara, K., Matsuda, T. Pulmonary pharmacology. (1995)
- Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 1st communication: absorption, concentrations in plasma, metabolism, and excretion after single administration to rats and dogs. Boberg, M., Ahr, H.J., Beckermann, B., Bühner, K., Siefert, H.M., Steinke, W., Wünsche, C., Hirayama, M. Arzneimittel-Forschung. (1997)